#United States #New York #Avista Healthcare #Bag Balm #Birchwell Health

Avista Healthcare Partners Launches Birchwell Consumer Health

Avista Healthcare Partners, a prominent private equity firm dedicated solely to the healthcare sector, has recently announced the establishment of a new consumer healthcare platform named Birchwell Consumer Health. This initiative is positioned to capture the growing market for over-the-counter (OTC) and skincare products through strategic acquisitions of innovative brands with high growth potential. The debut investment for Birchwell is the acquisition of Bag Balm, a renowned therapeutic skincare brand from Vermont that has been trusted since its founding in 1899.

Birchwell represents Avista's eighth global consumer healthcare platform and its fourth in North America, underscoring the firm's leadership in the healthcare investment space. This strategic move is aimed at leveraging the increasing demand for affordable self-care solutions and the rising popularity of effective OTC products.

The brand Bag Balm, known for its unique ability to treat various skin ailments, has built a loyal consumer base over its long history. The brand is recognized for its simple, effective formula encapsulated in its iconic Original Bag Balm tin, and it is widely distributed through major retail chains and e-commerce platforms. This expansion into new formats and applications demonstrates Bag Balm’s commitment to growth and consumer satisfaction.

Alex Yu, a Partner at Avista, expressed enthusiasm about this new venture, stating, "The launch of Birchwell signifies our unwavering belief in the potential of the consumer healthcare sector, characterized by fruitful merger and acquisition opportunities and supported by shifting consumer preferences towards accessible self-care products. The acquisition of Bag Balm perfectly embodies our strategy to secure trusted brands and enhance their market potential."

Fred Duchin, Strategic Executive at Avista and Chairman of Birchwell, described Bag Balm as the ideal type of brand to build around, highlighting its proven effectiveness and robust consumer loyalty. This acquisition sets a solid foundation for Birchwell's broader objectives in the consumer healthcare arena.

Bag Balm’s President, Libby Parent, indicated the importance of this transition, stating, "For more than a century, Bag Balm has been a trusted companion for families across America, offering solutions for their skincare needs. Partnering with Avista after a decade of growth allows us to further enhance our legacy and ensure the brand continues to resonate with consumers in the future."

Avista’s history in the consumer healthcare market includes previous investments in successful platforms such as WellSpring Consumer Healthcare and PK Consumer Health. These ventures are characterized by a focus on established OTC brands and innovative healthcare solutions. The firm’s approach involves collaborating with management teams to foster organic growth, enhance operational frameworks, and navigate strategic acquisitions effectively.

Founded in 2005, Avista Healthcare Partners has allocated over $10 billion across more than 50 growth-focused healthcare businesses worldwide. The firm's strategy centers on targeting enterprises equipped with strong leadership, stable revenue generation, and promising growth trajectories. By focusing on these aspects, Avista aims to capitalize on evolving healthcare needs driven by consumer trends towards wellness and self-care.

In summary, the launch of Birchwell Consumer Health is an exciting development in the healthcare investment landscape, combining Avista's strategic vision with the heritage of Bag Balm. As consumer demand for effective, accessible skincare products continues to rise, Birchwell is well-positioned to make a significant impact in the OTC market, providing consumers with trusted health solutions that enhance their everyday lives.

For more information, visit Avista Healthcare.